Spots Global Cancer Trial Database for grade iv astrocytoma
Every month we try and update this database with for grade iv astrocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | NCT02858895 | Glioblastoma Grade IV Astroc... Glioblastoma Mu... Grade IV Glioma | MDNA55 | 18 Years - | Medicenna Therapeutics, Inc. | |
| Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma | NCT04757662 | Grade III Astro... Grade IV Astroc... Astrocytoma, Gr... Astrocytoma, Gr... | Tadalafil | 18 Years - | Washington University School of Medicine | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical | |
| Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) | NCT01906385 | Glioma | Rhenium Liposom... | 18 Years - | Plus Therapeutics | |
| Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas) | NCT02772094 | Glioblastoma Mu... Glioblastoma | Single arm, ope... | 13 Years - 70 Years | China Medical University Hospital | |
| Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment | NCT05460507 | Glioma | Retreatment Rhe... | 18 Years - | Plus Therapeutics | |
| Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma | NCT02858895 | Glioblastoma Grade IV Astroc... Glioblastoma Mu... Grade IV Glioma | MDNA55 | 18 Years - | Medicenna Therapeutics, Inc. | |
| Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma | NCT04757662 | Grade III Astro... Grade IV Astroc... Astrocytoma, Gr... Astrocytoma, Gr... | Tadalafil | 18 Years - | Washington University School of Medicine | |
| Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM | NCT04489420 | Astrocytoma, Gr... Giant Cell Glio... Glioblastoma Mu... Cyclophosphamid... Immunosuppressi... Immunologic Fac... Physiological E... Molecular Mecha... Antiviral Agent... Anti-infective ... Analgesics, Non... Analgesics Sensory System ... Peripheral Nerv... | CYNK001-IV CYNK001-IT | 18 Years - | Celularity Incorporated | |
| Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor | NCT01470794 | Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Toca 511 vector Toca FC | 18 Years - 80 Years | Tocagen Inc. | |
| Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer | NCT00045968 | Glioblastoma Mu... Glioblastoma GBM Grade IV Astroc... Glioma Brain Cancer Brain Tumor | Dendritic cell ... | 18 Years - 70 Years | Northwest Biotherapeutics | |
| Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor | NCT01985256 | Glioblastoma Mu... Anaplastic Astr... Anaplastic Olig... Anaplastic Olig... | Toca 511 Toca FC | 18 Years - 80 Years | Tocagen Inc. | |
| A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 | NCT04327011 | Glioblastoma Mu... Astrocytoma Gliomas, Malign... | Toca 511 vector Toca FC • Flucy... | 18 Years - | Tocagen Inc. | |
| Study To Test the Safety and Efficacy of TVI-Brain-1 As A Treatment for Recurrent Grade IV Glioma | NCT01290692 | Grade IV Glioma Grade IV Astroc... Glioblastoma Mu... | TVI-Brain-1 | 18 Years - | TVAX Biomedical |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
